Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haploidentical Hematopoietic Stem Cell Transplantation With Early Antithymocyte Globulin and Low Dose Post-transplant Cyclophosphamide

NCT06041893 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT06041893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06041893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haploidentical Hematopoietic Stem Cell Transplantation With Early Antithymocyte Globulin and Low Dose Post-transplant Cyclophosphamide
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
May 29, 2023
Completion date
December 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

haploidentical hematopoietic stem cell transplantation